EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Gut Microbiota in Pulmonary Arterial Hypertension: Murine Models and Human Microbial Signatures, Pathogenic Mechanisms, and Emerging Therapeutic Avenues

Yudan Qiu, Xiaojiang Lyu, Dashuang Zhang, Hong Xu, Xu He, Jiao Chen, Hanmin Liu, Yang Liu iD, Liang Xie

Comprehensive Physiology · 2026-02 · 16 (1)

DOI: 10.1002/cph4.70094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Comprehensive Physiology, online erschienen am 06.01.2026. Verfasst von Yudan Qiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 184 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Science and Technology Projects of Xizang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a chronic, severe cardiopulmonary disease characterized by the progressive increase in pulmonary vascular resistance (PVR) because of the proliferation and fibrosis of the pulmonary arterioles. Although the disease originates in the pulmonary vasculature, it ultimately leads to right heart failure and death. PAH is associated with high mortality rates and poor prognosis, with no therapies currently available to reverse pulmonary vascular remodeling, imposing substantial socioeconomic burdens. Growing interest in the gut–lung axis has highlighted the role of gut microbiota and their metabolites in the occurrence and development of PAH. Evidence showed that gut dysbiosis and metabolite imbalances, involving reduced short‐chain fatty acids (SCFAs), increased trimethylamine‐N‐oxide (TMAO), and dysregulated tryptophan metabolism, contributed to pulmonary vascular remodeling. This review systematically compares gut microbiota and metabolites across PAH murine models (including chronic hypoxia, SU5416/hypoxia [SuHx], monocrotaline [MCT], and non‐classical models) and patients (adults and children). The analysis aims to identify disease‐specific microbial and metabolic signatures. It is also discussed how the microbiota and their metabolites may influence inflammation around the pulmonary vasculature. Furthermore, the potential of probiotic therapy, fecal microbiota transplantation (FMT), and mesenchymal stem cells (MSCs) therapies as novel treatment strategies for PAH is discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomePulmonary Arterial HypertensionHumansAnimalsMiceDisease Models, AnimalFecal Microbiota Transplantation

Stichwörter der Autor:innen

fecal microbiota transplantation (FMT)gut microbiotagut–lung axismicrobial metabolitesmurine modelspulmonary arterial hypertension (PAH)pulmonary vascular remodeling

Autor:innen und Institutionen

  • Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
  • The Joint Laboratory for Lung Development and Related Diseases of West China Second University Hospital, Sichuan University and School of Life Sciences of Fudan University, West China Institute of Women and Children's H…
  • Department of Pediatrics, Affiliated Hospital of North Sichuan Medical College, Sichuan, China.
  • NHC Key Laboratory of Chronobiology (Sichuan University), Chengdu, China.
  • Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

ORCID-Profile: Yang Liu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Science and Technology Projects of Xizang Autonomous Region
  • Sichuan Province Science and Technology Support Program
  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Qiu, Y., Lyu, X., Zhang, D., Xu, H., He, X., Chen, J., Liu, H., Liu, Y., & Xie, L. (2026). Gut Microbiota in Pulmonary Arterial Hypertension: Murine Models and Human Microbial Signatures, Pathogenic Mechanisms, and Emerging Therapeutic Avenues. Comprehensive Physiology, 16(1). https://doi.org/10.1002/cph4.70094

Vancouver

Qiu Y, Lyu X, Zhang D, Xu H, He X, Chen J, et al. Gut Microbiota in Pulmonary Arterial Hypertension: Murine Models and Human Microbial Signatures, Pathogenic Mechanisms, and Emerging Therapeutic Avenues. Comprehensive Physiology. 2026;16(1). doi:10.1002/cph4.70094

BibTeX
@article{Qiu2026,
  author = {Qiu, Yudan and Lyu, Xiaojiang and Zhang, Dashuang and Xu, Hong and He, Xu and Chen, Jiao and Liu, Hanmin and Liu, Yang and Xie, Liang},
  title = {Gut Microbiota in Pulmonary Arterial Hypertension: Murine Models and Human Microbial Signatures, Pathogenic Mechanisms, and Emerging Therapeutic Avenues},
  journal = {Comprehensive Physiology},
  year = {2026},
  volume = {16},
  number = {1},
  doi = {10.1002/cph4.70094}
}
Kostenlos starten →